Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

NCT00694148 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merz Pharmaceuticals GmbH